ADIAL PHARMACEUTICALS INC (ADIL) Stock Balance Sheet
NASDAQ:ADIL - Nasdaq - US00688A2050 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.20M | 2.83M | 4.00M | 6.06M | 4.40M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 414.24K | 371.60K | 780.00K | 400.00K | 730.00K | |||
| Total Current Assets | 5.62M | 3.20M | 4.78M | 6.46M | 5.14M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | 240.00K | 300.00K | N/A | |||
| Investments And Advances | 1.09M | 1.53M | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | 250.00K | 250.00K | N/A | |||
| Intangibles | 3.49K | 3.91K | 460.00K | 460.00K | 10.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.09M | 1.54M | 950.00K | 1.01M | 350.00K | |||
| TOTAL ASSETS | 6.71M | 4.74M | 5.73M | 7.47M | 5.49M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 510.93K | 525.69K | 1.39M | 2.43M | 860.00K | |||
| Accounts Payable | 318.12K | 127.39K | 390.00K | 290.00K | 650.00K | |||
| Other Current Liabilities | N/A | N/A | 10.00K | 10.00K | N/A | |||
| Total Current Liabilities | 829.05K | 653.08K | 1.79M | 2.72M | 1.51M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 20.00K | 20.00K | N/A | |||
| Other Non-Current Liabilities | N/A | N/A | 640.00K | 1.22M | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 670.00K | 1.25M | 0.00 | |||
| TOTAL LIABILITIES | 829.05K | 653.08K | 2.46M | 3.97M | 1.51M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -79.92M | -68.80M | -63.67M | -50.94M | -31.52M | |||
| Additional Paid In Capital | 85.80M | 72.88M | 66.92M | 54.43M | 35.49M | |||
| Common Shares | 6.40K | 1.66K | 30.00K | 20.00K | 10.00K | |||
| Shares Outstanding | 6.41M | 1.66M | 1.07M | 840.00K | 580.00K | |||
| Tangible Book Value per Share | 0.92 | 2.45 | 2.40 | 3.33 | 6.86 | |||
| Total Shareholders' Equity | 5.88M | 4.08M | 3.28M | 3.51M | 3.99M | |||
| TOTAL LIABILITIES AND EQUITY | 6.71M | 4.74M | 5.73M | 7.47M | 5.49M | |||
| Statistics | ||||||||
| Current Ratio | 6.78 | 4.90 | 2.67 | 2.38 | 3.40 | |||
| Return On Assets (ROA) | -194.36% | -108.16% | -222.16% | -259.97% | -198.36% | |||
| Return On Equity (ROE) | -221.75% | -125.46% | -388.11% | -553.28% | -272.93% | |||
All data in USD , ROIC based on taxRate of 0.21